JP2014520892A5 - - Google Patents

Download PDF

Info

Publication number
JP2014520892A5
JP2014520892A5 JP2014521786A JP2014521786A JP2014520892A5 JP 2014520892 A5 JP2014520892 A5 JP 2014520892A5 JP 2014521786 A JP2014521786 A JP 2014521786A JP 2014521786 A JP2014521786 A JP 2014521786A JP 2014520892 A5 JP2014520892 A5 JP 2014520892A5
Authority
JP
Japan
Prior art keywords
botulinum
composition according
botulinum toxin
type
toxin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014521786A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014520892A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/047405 external-priority patent/WO2013013042A1/en
Publication of JP2014520892A publication Critical patent/JP2014520892A/ja
Publication of JP2014520892A5 publication Critical patent/JP2014520892A5/ja
Pending legal-status Critical Current

Links

JP2014521786A 2011-07-20 2012-07-19 脂肪沈着物を処置するための方法におけるボツリヌス毒素の使用 Pending JP2014520892A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161509700P 2011-07-20 2011-07-20
US61/509,700 2011-07-20
PCT/US2012/047405 WO2013013042A1 (en) 2011-07-20 2012-07-19 Botulinum toxins for use in a method for treatment of adipose deposits

Publications (2)

Publication Number Publication Date
JP2014520892A JP2014520892A (ja) 2014-08-25
JP2014520892A5 true JP2014520892A5 (enExample) 2016-06-16

Family

ID=46601917

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014521786A Pending JP2014520892A (ja) 2011-07-20 2012-07-19 脂肪沈着物を処置するための方法におけるボツリヌス毒素の使用

Country Status (12)

Country Link
US (1) US20140127188A1 (enExample)
EP (1) EP2734224A1 (enExample)
JP (1) JP2014520892A (enExample)
KR (1) KR20140082956A (enExample)
CN (1) CN103702681A (enExample)
AU (1) AU2012283968B2 (enExample)
BR (1) BR112014001066A2 (enExample)
CA (1) CA2841955A1 (enExample)
IN (1) IN2014DN00254A (enExample)
MX (1) MX2014000612A (enExample)
RU (1) RU2014103543A (enExample)
WO (1) WO2013013042A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
US9655926B1 (en) 2013-08-23 2017-05-23 Amiya Prasad Treatment for hair thinning and hair loss
WO2016021985A1 (ko) * 2014-08-07 2016-02-11 김상덕 보툴리눔 독소와 공기의 혼합물을 포함하는 안면 윤곽 교정용 조성물 및 이를 이용한 안면 윤곽 교정 방법
TWI722077B (zh) 2015-12-18 2021-03-21 中國大陸商江蘇南大光電材料股份有限公司 製造有機胺基矽烷之方法;自該有機胺基矽烷製造矽烷胺之方法
EP3541358A1 (en) 2016-11-21 2019-09-25 Eirion Therapeutics, Inc. Transdermal delivery of large agents
JP2020520917A (ja) * 2017-05-18 2020-07-16 ルバンス セラピュティックス インク.Revance Therapeutics,Inc. 頸部ジストニアの治療方法
US20190030118A1 (en) * 2017-07-27 2019-01-31 Ipsen Biopharm Limited Treatment of lower limb spasticity

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9120306D0 (en) 1991-09-24 1991-11-06 Graham Herbert K Method and compositions for the treatment of cerebral palsy
US5437291A (en) 1993-08-26 1995-08-01 Univ Johns Hopkins Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
US6974578B1 (en) 1993-12-28 2005-12-13 Allergan, Inc. Method for treating secretions and glands using botulinum toxin
US5766605A (en) 1994-04-15 1998-06-16 Mount Sinai School Of Medicine Of The City University Of New York Treatment of autonomic nerve dysfunction with botulinum toxin
EP1086702B1 (en) 1994-05-09 2005-04-13 BINDER, William J. Presynaptic neurotoxins for treatment of migraine headache
US5670484A (en) 1994-05-09 1997-09-23 Binder; William J. Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders
GB9508204D0 (en) 1995-04-21 1995-06-07 Speywood Lab Ltd A novel agent able to modify peripheral afferent function
DE69841291D1 (de) 1997-07-15 2009-12-31 Univ Colorado Verwendung von Botulinumtoxin zur Behandlung der renitenten Blasenentleerungsstörung
US6063768A (en) 1997-09-04 2000-05-16 First; Eric R. Application of botulinum toxin to the management of neurogenic inflammatory disorders
US6113915A (en) 1999-10-12 2000-09-05 Allergan Sales, Inc. Methods for treating pain
US6265379B1 (en) 1999-10-13 2001-07-24 Allergan Sales, Inc. Method for treating otic disorders
US6139845A (en) 1999-12-07 2000-10-31 Allergan Sales, Inc. Method for treating cancer with a neurotoxin
US6143306A (en) 2000-01-11 2000-11-07 Allergan Sales, Inc. Methods for treating pancreatic disorders
US6358513B1 (en) 2000-02-15 2002-03-19 Allergan Sales, Inc. Method for treating Hashimoto's thyroiditis
US6319506B1 (en) * 2000-02-22 2001-11-20 Allergan, Sales, Inc. Method for treating hypercalcemia
US6464986B1 (en) 2000-04-14 2002-10-15 Allegan Sales, Inc. Method for treating pain by peripheral administration of a neurotoxin
US6299893B1 (en) 2000-04-17 2001-10-09 Marvin Schwartz Method to reduce hair loss and stimulate hair regrowth
US6306423B1 (en) 2000-06-02 2001-10-23 Allergan Sales, Inc. Neurotoxin implant
US6306403B1 (en) 2000-06-14 2001-10-23 Allergan Sales, Inc. Method for treating parkinson's disease with a botulinum toxin
US6423319B1 (en) 2000-10-04 2002-07-23 Allergan Sales, Inc. Methods for treating muscle injuries
EP2272340B1 (en) * 2002-08-19 2018-03-14 Ira Sanders Botulinum toxin
CA2558408C (en) * 2004-03-03 2014-11-18 Essentia Biosystems, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
US7179474B2 (en) * 2004-09-03 2007-02-20 Allergan, Inc. Methods for treating a buttock deformity
US20060057165A1 (en) * 2004-09-10 2006-03-16 Dimitrios Dimitrakoudis Clostridium botulinum toxin formulation and method for reducing weight
US7727537B2 (en) * 2005-02-14 2010-06-01 Dpm Therapeutics Corp. Stabilized compositions for topical administration and methods of making same
US20080220021A1 (en) * 2005-02-14 2008-09-11 Pankaj Modi Topical Botulinum Toxin Compositions for the Treatment of Hyperhidrosis
CN101374498A (zh) * 2005-12-01 2009-02-25 麻萨诸塞州洛厄尔大学 肉毒杆菌纳米乳液
EP2197409A1 (en) * 2007-08-31 2010-06-23 DSM IP Assets B.V. 4-amidino benzylamines for cosmetic and/or dermatological use
US20090297632A1 (en) * 2008-06-02 2009-12-03 Waugh Jacob M Device, Methods and Compositions to Alter Light Interplay with Skin
KR102080429B1 (ko) * 2008-06-26 2020-02-21 안테리오스, 인코퍼레이티드 경피 운반
AU2010220830B2 (en) * 2009-03-02 2016-07-14 Nova Scientifica Llc Medicinal cosmetic lipoatrophy

Similar Documents

Publication Publication Date Title
JOP20230073A1 (ar) بنزاميدات مستبدلة مع 3،1- ثيازول-2- يل
JP2014505733A5 (enExample)
JP2010222367A5 (enExample)
WO2014205389A8 (en) Nuclear transport modulators and uses thereof
IN2014MN02288A (enExample)
IN2014DN09434A (enExample)
BR112014032699A2 (pt) métodos de tratamento de síndrome metabólica pediátrica
MX2013003635A (es) Compuestos de n-heteroarilo.
EA201391119A1 (ru) Системы доставки наночастиц, их получение и применение
WO2017022962A8 (ko) Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물
PH12017500706B1 (en) Composition containing extract or fraction of genus justicia plant
WO2015195684A3 (en) Small molecule anti-scarring agents
WO2016191458A3 (en) Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment
WO2016030899A8 (en) Methods of treating amyotrophic lateral scleroses
MX2016000294A (es) Composicion farmaceutica para liberacion sostenida de lanreotida.
BR112016007238A2 (pt) tienouracilcarboxamidas cíclicas e sua utilização
UA118474C2 (uk) (s)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині
NZ700467A (en) Treatments suitable for malassezia infections
BR112015027992A2 (pt) uso de ácido petroselínico para combater desordens estéticas da figura do corpo
JP2016175884A5 (enExample)
JP2015508052A5 (enExample)
WO2015004634A3 (es) Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio
EA201690574A1 (ru) Применение пидотимода в лечении заболеваний, связанных с воспалением
UA109944U (uk) Фармацевтична композиція для зниження рівня n-оксиду триметиламіну
IN2014DN10134A (enExample)